TRANSFORMED B-CELL LYMPHOMA
Clinical trials for TRANSFORMED B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new TRANSFORMED B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for TRANSFORMED B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Armored immune cells take on tough blood cancers in early trial
Disease control OngoingThis early-phase study tests the safety of specially engineered immune cells (armored CAR T cells) in people with certain blood cancers that have not responded to standard treatments. The cells are made from the patient's own blood and designed to better target and attack cancer …
Matched conditions: TRANSFORMED B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New immunotherapy combo shows promise for Tough-to-Treat lymphoma
Disease control OngoingThis early-phase trial is testing whether adding the immunotherapy drug mosunetuzumab to standard chemotherapy can safely treat aggressive B-cell lymphoma that has come back or not responded to treatment. About 24 adults will receive either DHAX or ICE chemotherapy plus mosunetuz…
Matched conditions: TRANSFORMED B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC